| Literature DB >> 17575505 |
Beth A Pletcher1, Helga V Toriello, Sarah J Noblin, Laurie H Seaver, Deborah A Driscoll, Robin L Bennett, Susan J Gross.
Abstract
Entities:
Mesh:
Year: 2007 PMID: 17575505 PMCID: PMC3110962 DOI: 10.1097/gim.0b013e318064e70c
Source DB: PubMed Journal: Genet Med ISSN: 1098-3600 Impact factor: 8.822
Genetic consultation may be helpful under the following circumstances for preconceptional or prenatal patients
| Prenatal or preconceptional patient who is or will be: | |
| Finding | Reason to consider consultation |
| Age 35 years or older at the time of delivery (for a singleton pregnancy) | Discuss testing options for identifying an age-related chromosome anomaly |
| Age 33 years or older at the time of delivery (for a twin pregnancy) | Discuss testing options for identifying an age-related chromosome anomaly |
| A close blood relative of her partner (consanguineous union) | Review pedigree and assess degree of relatedness; discuss potential additional fetal risks and testing options before and/or after delivery |
| Prenatal or preconceptional patient who has: | |
| Finding | Reason to consider consultation |
| An abnormal first or second trimester maternal serum ± nuchal translucency screening test | Discuss risks to pregnancy and testing options |
| Exposure to a teratogen or potentially teratogenic agent during gestation such as radiation, high-risk infections (cytomegalovirus, toxoplasmosis, rubella), drugs, medications, alcohol, etc. | Discuss risks to pregnancy and testing options and rule out significant fetal ± maternal risks |
| A fetal anomaly or multiple anomalies identified on ultrasound and/or through echocardiography | Discuss risks to pregnancy and testing options |
| A personal or family history of pregnancy complications known to be associated with genetic factors such as acute fatty liver of pregnancy | Rule out significant fetal risks ± maternal risks, including a metabolic disorder |
| Either member of the couple with: | |
| Finding | Reason to consider consultation |
| A positive carrier screening test for a genetic condition such as cystic fibrosis, thalassemia, sickle cell anemia, Tay-Sachs, etc. | Discuss additional testing strategies and inheritance |
| A personal history of stillbirths, previous child with hydrops, recurrent pregnancy losses (more than two), or a child with sudden infant death syndrome (SIDS) | Rule out a chromosomal, metabolic, or syndromic diagnosis that may be associated with an unexplained neonatal death or SIDS |
| A progressive neurologic condition known to be genetically determined such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, early onset dementia, or a familial movement disorder | Discuss a potential diagnosis, the differential diagnosis, inheritance, and testing options |
| A statin-induced myopathy | Discuss a potential mitochondrial disorder, inheritance and testing options |
| Either member of the couple with a family or personal history of: | |
| Finding | Reason to consider consultation |
| A birth defect such as a cleft lip ± palate, spina bifida, or a congenital heart defect | Discuss recurrence risks and testing options; discuss folate supplementation, if appropriate, for subsequent pregnancies |
| A chromosomal abnormality such as a translocation, marker chromosome, or chromosomal mosaicism | Discuss risks to the fetus and testing options |
| Significant hearing or vision loss thought to be genetically determined | Discuss risks to the fetus and testing options |
| Mental retardation or autism | Discuss risks to the fetus and testing options |
Genetic consultation may be helpful under the following circumstances for pediatric patients
| A neonate with: | |
| Finding | Reason to consider consultation |
| An abnormal newborn screening test | Rule out an inborn error of metabolism or other treatable condition; provide genetic counseling about recurrence risks |
| Congenital hypotonia or hypertonia | Rule out a chromosomal, metabolic, or syndromic diagnosis (e.g., Prader-Willi syndrome, congenital myotonic dystrophy, hyperekplexia). |
| Unexplained intrauterine growth retardation | Rule out a chromosomal or syndromic diagnosis (e.g., Russell-Silver syndrome, trisomy 18) |
| A neonate, infant, or child with: | |
| Finding | Reason to consider consultation |
| A single major, or multiple major and/or minor anomalies | Rule out a chromosomal or syndromic diagnosis; provide genetic counseling for recurrence and possible preventive measures (e.g., folate supplementation in subsequent pregnancies) |
| Dysmorphic features that are not familial, especially if accompanied by developmental delay or mental retardation | Rule out a chromosomal or syndromic diagnosis (numerous conditions) |
| Failure to thrive | Rule out a chromosomal, metabolic, or syndromic diagnosis, or genetic condition (e.g., IGF1R mutations) |
| A known metabolic disorder or symptoms of a metabolic disorder such as intractable seizures, hepatosplenomegaly, acidosis, cyclic vomiting, persistent hypoglycemia, developmental regression, and unusual body odor | Diagnose an inborn error of metabolism; discuss treatment and management; provide genetic counseling |
| Abnormal brain MRI findings such as leukodystrophy, periventricular calcifications, unidentified bright objects, or a malformation | Rule out a chromosomal or syndromic diagnosis (e.g., neurofibromatosis, tuberous sclerosis); provide genetic counseling (e.g., some brain malformations such as Dandy-Walker malformation may be genetic) |
| An unusual growth pattern such as overgrowth, short stature, or hemihypertrophy | Rule out a chromosomal, syndromic, or metabolic diagnosis (e.g., Sotos syndrome, Beckwith-Wiedemann syndrome, Turner syndrome) |
| Evidence of a connective tissue disorder such as extreme joint laxity, poor wound healing, or a marfanoid habitus | Rule out a connective tissue disorder, such as Ehlers-Danlos syndrome, Marfan syndrome |
| Congenital eye defects or blindness associated with problems such as microophthalmia, cataracts, megalocornea, retinitis pigmentosa, or cone-rod dystrophy | Rule out a syndromic diagnosis; provide genetic counseling for potentially hereditary ocular conditions |
| Significant hearing loss or deafness not secondary to recurrent otitis media | Rule out a syndromic form of hearing loss (e.g., Waardenburg syndrome) or identify a genetic form of nonsyndromic hearing loss |
| Cardiomyopathy not secondary to a viral infection | Rule out a mitochondrial disorder or other syndromic or metabolic diagnosis (e.g., carnitine deficiencies, Noonan syndrome, several forms of muscular dystrophy); provide genetic counseling for potentially hereditary forms of cardiomyopathy |
| Six or more café-au-lait macules >0.5 cm in diameter | Rule out neurofibromatosis type 1 |
| Unusual skin findings such as multiple types of lesions, multiple lipomas, numerous hypo- or hyperpigmented lesions, and albinism | Rule out a chromosomal or syndromic diagnosis (e.g., chromosomal mosaicism, tuberous sclerosis, Cowden syndrome) |
| Born to a parent with a known chromosomal abnormality or rearrangement (balanced or unbalanced), especially if there are dysmorphic features and/or cognitive impairment | Rule out a chromosomal abnormality |
| Bilateral or multifocal malignancies such as retinoblastoma or Wilms tumor | Rule out a cancer syndrome or other chromosomal or syndromic diagnosis (e.g., aniridia-Wilms tumor caused by 11p13 deletion); provide genetic counseling for recurrence |
| Problems with clotting including disorders such as hemophilia and thrombophilia | Rule out an inherited clotting disorder as well as some syndromes (e.g., Noonan syndrome) |
| A recognized or suspected genetic syndrome including a chromosomal or single gene disorder | Confirm the diagnosis and discuss the prognosis, medical management, inheritance, and recurrence risks |
| A significant family history of medical or psychiatric conditions that puts the patient at risk of developing the same or similar disorder | Discuss diagnosis, inheritance, and possible testing options |
| A child with: | |
| Finding | Reason to consider consultation |
| Unexplained mental retardation or global developmental disorder | Rule out a chromosomal, syndromic or metabolic diagnosis (e.g., fragile X, sex chromosome anomaly, some forms of mucopolysaccharidoses) |
| Autism or pervasive developmental disorder | Rule out a chromosomal or syndromic diagnosis (e.g., fragile X, Angelman syndrome, Rett syndrome) |
| Unusual behaviors, especially when associated with minor malformations and developmental delay or mental retardation | Rule out a chromosomal or syndromic diagnosis (e.g., Smith-Magenis syndrome, Lesch-Nyhan syndrome) |
| An immunodeficiency or significant immune problem | Rule out a syndromic diagnosis (e.g., 22q deletion) or genetic form of immunodeficiency (e.g., severe combined immunodeficiency syndrome) |
| Progressive muscle weakness that might be associated with a genetic disorder such as a form of muscular dystrophy, spinal muscular atrophy, or myotonic dystrophy | Confirm suspected diagnosis and provide genetic counseling |
| Other neurologic condition that might be associated with a genetic predisposition such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, or any progressive neurologic disorder without a clear, nongenetic cause | Rule out a genetic diagnosis (e.g., spinocerebellar ataxia, Huntington disease), provide genetic counseling |
Genetic consultation may be helpful under the following circumstances for adult patients
| Personal history of: | |
| Finding | Reason to consider consultation |
| Abnormal sexual maturation or delayed puberty | Rule out an intersex condition, chromosomal abnormality or syndromic diagnosis (e.g., androgen insensitivity, Klinefelter syndrome) |
| Recurrent pregnancy losses (RPLs) (more than 2) | Rule out a chromosomal rearrangement such as a balanced translocation or inversion; causes 5%–7% of RPLs |
| Tall or short stature for genetic background | Rule out a skeletal dysplasia, chromosomal or syndromic diagnosis (e.g., dyschondrosteosis, Klinefelter syndrome, Marfan syndrome) |
| One or more birth defects | Rule out a chromosomal or syndromic diagnosis (e.g., 22q deletion, Noonan syndrome); provide genetic counseling and discussion of preconception folate supplementation, if appropriate |
| Six or more café-au-lait macules > 1.5 cm in diameter | Rule out neurofibromatosis type 1 |
| Statin-induced myopathy | Rule out a mitochondrial disorder |
| Personal or family history of: | |
| Finding | Reason to consider consultation |
| A cancer or cancers known to be associated with specific genes or mutations such as breast, ovarian, and colorectal in the context of a compelling family history; young age at onset, bilateral lesions, and familial clustering of related tumors | Rule out an identifiable mutation in a gene such as BRCA1, FAP, etc.; rule out a cancer syndrome (e.g., MEN2 or von Hippel-Lindau); discuss surveillance, treatment, testing options (if presymptomatic), and inheritance |
| Cardiovascular problems known to be associated with genetic factors such as cardiomyopathy, long QT, hyperlipidemia, etc. | Rule out a mutation in a causative or contributory gene; discuss surveillance, treatment, testing options, and inheritance |
| Suspected genetic disorder affecting connective tissue | Rule out a syndromic diagnosis (e.g., Ehlers-Danlos, Marfan syndrome, familial joint hypermobility); discuss surveillance, treatment, testing options, and inheritance |
| Hematologic condition associated with excessive bleeding or excessive clotting (as evidenced by recurrent deep vein thromboses or pulmonary emboli) | Confirm or rule out genetic condition (e.g., one of the hemophilias, von Willebrand, one of the genetic thrombophilias); discuss treatment, testing options, and inheritance |
| Progressive neurologic condition known to be genetically determined such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, early-onset dementia, and a familial movement disorder | Confirm or rule out suspected diagnosis, discuss surveillance, treatment, testing options, and inheritance |
| Visual loss known to be associated with genetic factors such as retinitis pigmentosa, early-onset macular degeneration, and cataracts | Rule out a syndromic diagnosis (e.g., Stickler syndrome); discuss testing options, if applicable, and inheritance |
| Early-onset hearing loss | Rule out a syndromic or nonsyndromic genetic form of hearing loss; discuss surveillance, testing options, and inheritance |
| Recognized genetic disorder including a chromosomal or single gene disorder | Confirm the diagnosis; discuss prognosis, medical management, and inheritance |
| Mental illness such as schizophrenia, depression, bipolar disorder, etc. | Discuss diagnosis, inheritance, recurrence risks, and identify syndromes (e.g., 22q deletion), when possible |
| Family history of: | |
| Finding | Reason to consider consultation |
| A close relative with a sudden, unexplained death, particularly at a young age | Rule out a genetic condition associated with this history, e.g., long QT, Marfan syndrome, and other cardiac conditions |